Dr.Lisa Barraclough – Best Costs, Reviews – Book Your Consultation

Professional Experience

• Consultant Clinical Oncologist at The Christie since 2008
• Head (lead) of the Gynaecological Clinical Oncology Disease Group at The Christie, overseeing a team of 3 oncologists managing gynaecological cancers across Greater Manchester and Cheshire
• Management of outpatient, inpatient, radiotherapy, brachytherapy, and systemic therapy services within the gynaecology MDT setting
• Participation in pioneering radiotherapy delivery such as use of MR-guided linear accelerator (MR-linac) in cervical cancer treatment

Academic Contributions

• Active contributor to clinical trials and radiotherapy research, especially in gynaecological cancers
• Listed on ResearchGate with a portfolio of publications in oncology and radiotherapy
• Speaker at oncology conferences and participant in guideline/quality assurance work in radiation oncology
• Mentorship and involvement in multidisciplinary tumour boards in breast and gynaecology cancer services

Areas of Expertise

• Gynaecological cancers (cervix, endometrium, vulva, vagina) — radiotherapy, brachytherapy, systemic therapy
• Breast cancer treatments within her interest scope
• Use of advanced radiotherapy techniques, including MR-linac guided radiotherapy for precise tumour targeting
• Integrating multimodal care (radiation plus chemotherapy/targeted therapy) in complex cases
• Gynaecology oncology service leadership, pathway development and MDT coordination

Publications and Research

Patient Care Philosophy

• Clear, empathetic communication: explaining complex oncology and radiotherapy in understandable language
• Shared decision-making: engaging patients in planning their care pathways
• Use of advanced technology to minimize side effects and preserve healthy tissue (e.g. MR-guided RT)
• Close coordination in multidisciplinary teams to ensure seamless patient journeys
• Openness to research and innovation when it benefits patient outcomes and safety

Professional Affiliations

• Fellow of the Royal College of Radiologists (FRCR)
• Member of national oncology networks and clinical trial groups in gynaecology oncology (led her disease group)
• GMC registered consultant (GMC number 4186205)
• Involvement in radiotherapy guideline and protocol committees at regional/national levels

FAQs

Is Dr Lisa Barraclough board-certified?

Yes — she holds FRCR and is a registered Consultant Clinical Oncologist in the UK.

What cancers does she treat?

She treats gynaecological cancers (cervical, uterine, vulval, vaginal) and also has interests in breast oncology.

Does she accept international patients?

Her primary practice is at The Christie NHS. She may see patients via The Christie Private Care, which can accept international referrals.

How advanced is the radiotherapy she uses?

She is involved in state-of-the-art techniques including MR-guided radiotherapy (MR-linac), allowing more accurate targeting and reduced side effects.

How long are radiotherapy courses?

It depends on the protocol and cancer type; courses may run over several weeks, with fractionated dosing tailored to the patient.

Is she active in research and trials?

Yes — she is actively engaged in clinical trials and innovative radiotherapy research in gynaecological oncology.

What languages does she speak?

Her professional language is English; public sources do not list other languages.